L.M. Keilson
Publications by Year
Research Areas
Lipoproteins and Cardiovascular Health, Cancer, Lipids, and Metabolism, Lipid metabolism and disorders, Diabetes, Cardiovascular Risks, and Lipoproteins, Acute Myeloid Leukemia Research
Most-Cited Works
- → Effects of simvastatin, an HMG‐CoA reductase inhibitor, in patients with hypertriglyceridemia(2003)30 cited
- → Lipid altering efficacy of simvastatin in patients with hypertriglyceridemia(1999)1 cited
- → Large and dose dependent effects of simvastatin 40 and 80 mg/day in combined hyperlipidemia(1999)1 cited
- → Atorvastatin, a new HMG-CoA reductase inhibitor (HMGRI), is safe and effective in hypertriglyceridemic patients(1994)1 cited
- → The efficacy of simvastatin in patients with hypertriglyceridemia(1999)1 cited
- → Simvastatin treatment in patients with type 2 diabetes and combined hyperlipidemia(1999)
- Effects of lipid lowering therapy on platelet activation invivo(1992)
- → 1.P.45 Prevalence of LPL mutations, Gly188 → Glu, Pro207 → Leu, Asp250 → Asn, and Asn291 → Ser, amongst patients with elevated triglyceride levels (TG > 11.29 mmol/l) in an American population of French Canadian ancestry(1997)
- → Lipid altering efficacy of simvastatin in type III hyperlipidemia(1999)